Business

Result of General Meeting and Total Voting Rights

Result of General Meeting and Total Voting Rights.

articleArecor Therapeutics PlcAugust 8, 20245/company/arecor-therapeutics-plc/news/result-of-general-meeting-and-total-voting-rights-13
Result of General Meeting and Total Voting Rights

About this update from Arecor Therapeutics Plc

[{"type":"text","content":"\n\nTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.\n \nTHIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN ARECOR THERAPEUTICS PLC OR ANY OTHER ENTITY IN ANY JURISDICTION.\n \n8 August 2024\n \nArecor Therapeutics plc\n \n(\"Arecor Therapeutics\" or the \"Company\")\n \nResult of General Meeting and Total Voting Rights\n \nArecor Therapeutics (AIM: AREC), the biopharmaceutical group advancing today's therapies to enable healthier lives, is pleased to announce that the Resolutions to approve, inter alia, the proposed Placing, Subscription and Retail Offer as set out in the Circular published on 23 July 2024, and put to Shareholders at the General Meeting held earlier today, were duly passed. A summary of the voting results is set out below.\n \nResult of General Meeting\n \nThe Board reports that Resolution 1 passed as an ordinary resolution and Resolution 2 passed as a special resolution.  Following the passing of the Resolutions, the Company has received the authority for the Directors to allot and issue the Placing Shares, Subscription Shares and Retail Offer Shares.\n \nThe proxy voting results of the Resolutions are included below:\n \n\n\n\n\nResolution\n\n\nFOR\n\n\nAGAINST\n\n\nTOTAL\n\n\nWITHHELD\n\n\n\n\n \n\n\nNo. of votes cast\n\n\n%\n\n\nNo. of votes cast\n\n\n%\n\n\nNo. of votes cast\n\n\nNo.\n\n\n\n\nResolution 1\nTo grant the directors authority to allot shares in the Company pursuant to the Fundraising in the amount set out in the Notice of General Meeting\n\n\n14,685,460\n\n\n99.97\n\n\n4,968\n\n\n0.03\n\n\n14,690,428\n\n\n310\n\n\n\n\nResolution 2\nConditionally on the passing of Resolution 1, to empower the directors to disapply pre-emption rights on the issue of shares in the Company pursuant to the Fundraising in the amount set out in the Notice o...

More updates from Arecor Therapeutics Plc